Condition: Long-COVID · Sponsor: VA Office of Research and Development
The proposed focuses on improving both morbidity and mortality in older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to augment vascular endothelial function by combating the oxidative stress and inflammation associated with aging and further induced by COVID-19. The investigators expected outcomes will have an important positive impact because they will provide scientifically sound recommendations for rehabilitation to improve vascular endothelial function and minimize the long-term consequences of COVID-19.
This description comes directly from the study's public registry record.
Joel D Trinity, PhD · (801) 582-1565 · Joel.Trinity@va.gov
Russell S Richardson, PhD · (801) 582-1565 · r.richardson@hsc.utah.edu
Always discuss trial participation with your own doctor first.
| VA Salt Lake City Health Care System, Salt Lake City, UT | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05373043